Study shows role of disease-fighting cells in HIV-related neurological damage
Findings add to evidence macrophage accumulation is central to brain injury
Dyes illuminate macrophage and monocyte cells as they arrive in the brain, where their presence is tied to neurological damage in people otherwise living symptom-free with HIV. By using different... view more
Amer. Journal of Pathology
CHESTNUT HILL, MA (May 12, 2015) - Despite symptom-stifling anti-retroviral drugs,
as many as half of all patients living with HIV experience neurological damage tied to chronic
inflammation in the brain fueled by the body's own immune defenses.
In an effort to understand why patients who appear virus free are afflicted with AIDS-related dementia
and other illnesses, researchers have focused on disease-fighting cells, called macrophages and
monocytes, as they traffic throughout the body and into the brain.
But little has been known about the timing and dynamics behind these types of white blood cells as
they invade the central nervous system during the initial stages of HIV infection or at the onset of AIDS.
A new investigative approach in SIV-infected rhesus monkeys has yielded fresh clues that show the
caustic interplay between macrophage and monocyte traffic in the central nervous system and the
onset of HIV infection and the formation of brain lesions tied to neurological damage,
according to a new report in the online edition of the American Journal of Pathology .
Researchers from Boston College, the University of Florida and Tulane University Health Science
Center report macrophages accumulate in different parts of the brain during different stages of
initial infection, a finding that clarifies the spread of infection to the brain is a
multi-layered and dynamic process.
"This type of approach allowed us to label macrophages in the perivascular space in the brain to
identify macrophage and monocyte traffic to the brain in the early, mid and late stages of
infection," said Boston College Professor of Biology Kenneth Williams, the senior author
of the report. "We now know what cells bring the virus to the brain and what cells
contribute to neurological damage in the brain, as well as the timing of the
entry of these cells and when the pathologic virus enters. These are two
big questions researchers have had."
The researchers tagged monocytes, destined to enter the brain, in bone marrow with a biochemical marker
known as BrdU and also used a series of different color dyes to label macrophages as they entered the
central nervous system at different times in infection, including early, mid and terminal states.
As infection progressed, the researchers found MAC387 macrophages accumulated in the meninges
and choroid plexus in early-stage brain infection. Later on, MAC387 macrophages were found
in perivascular spaces that surround arteries and veins in the brain, as well as at sites
where brain lesions would form.
Another macrophage, known as CD163 macrophages, was traced to perivascular space and brain lesions
during the late stage, the team reports. Late in infection, the volume of macrophages entering the
brain was nearly three times as great as during early-stage infection.
"An important question researchers have is what drives the pathology and the resulting damage in the
brain?" said Williams. "Is it the virus itself or macrophage and monocyte cells? What we found is that
these cells that arrive late with the development of AIDS have a 2.9-fold higher percentage of being
infected with the virus. So there is a dramatic increase in the viral load as infection progresses
that correlates to macrophage accumulation."
Turning their attention to lesion formation, the researchers discovered that greater than 80 percent
of the macrophages found in the lesions were present in the brain prior to lesion formation. The
surprising finding suggests the cells in the lesions migrated from non-lesion sites in the
brain rather than from outside the brain.
"Brain lesions are central to understanding what causes AIDS-related dementia," said Williams. "In
early stages of infection, we could see two or three macrophages scattered along the vessel. By the
late stage, when lesions appeared, there were 30 to 50 at the site. What we found is that a
majority of the cells in the lesions were present in the brain at an early stage. So these
macrophages are migrating from the brain to the lesion sites, which shows a complex and
dynamic level of activity."
http://www. bc. edu
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS: